|
Market Closed -
Toronto S.E.
15:42:34 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 31.43 CAD | +2.01% |
|
+3.29% | +24.28% |
| 10-19 | Gilead Sciences, Inc. Presents New Findings From Its HIV And Antiviral Research And Development Programs At IDWeek 2026 | CI |
| 10-19 | Gilead's pill succeeds in mid-stage bowel disease trial | RE |
| Market Cap | 190B 169B 157B 142B 267B 17,987B 271B 1,875B 737B 9,412B 712B 697B 30,039B | P/E 2026 * |
-44.7x | P/E 2027 * | 19x |
|---|---|---|---|---|---|
| Enterprise Value | 211B 188B 174B 158B 297B 20,003B 301B 2,085B 820B 10,467B 792B 775B 33,406B | EV / Sales 2026 * |
6.87x | EV / Sales 2027 * | 6.19x |
| Free-Float |
99.89% | Yield 2026 * |
2.15% | Yield 2027 * | 2.19% |
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| GILD | Delayed | |
Deutsche Boerse AG
| GIS0 | Delayed |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +2.01% | ||
| 1 week | +3.29% | ||
| Current month | +4.56% | ||
| 1 month | +3.90% | ||
| 3 months | +15.59% | ||
| 6 months | +12.05% | ||
| Current year | +24.28% |
| 1 week | 29.84 |  | 32.18 |
| 1 month | 28.94 | | 32.18 |
| Current year | 23.97 | | 32.18 |
| 1 year | 23.62 | | 32.18 |
| 3 years | 20.08 | | 32.18 |
| 5 years | 20.08 | | 32.18 |
| 10 years | 20.08 | | 32.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 2019-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 2019-10-31 |
Keeley Wettan
CMP | Compliance Officer | - | 2025-12-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 2016-08-18 |
| Director/Board Member | 73 | 2017-12-31 | |
Harish Manwani
BRD | Director/Board Member | 72 | 2018-05-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.01% | +3.29% | - | - | 190B | |
| +3.49% | +8.54% | +59.89% | +117.27% | 1,106B | |
| +2.19% | -1.66% | +34.23% | +70.27% | 612B | |
| +2.26% | +2.83% | +25.92% | +98.65% | 500B | |
| +2.58% | +8.31% | +37.43% | +63.51% | 367B | |
| +3.25% | +1.96% | +74.90% | +47.67% | 354B | |
| +1.85% | +5.45% | +21.38% | +49.26% | 286B | |
| +1.76% | +4.92% | +0.48% | +20.31% | 256B | |
| +3.29% | +5.12% | +46.90% | +56.43% | 230B | |
| +2.25% | +4.04% | +27.44% | +99.53% | 190B | |
| Average | +0.96% | +2.13% | +36.51% | +69.21% | 433.35B | |
| Weighted average by Cap. | +0.51% | +2.30% | +41.69% | +80.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.73B 27.37B 25.37B 22.98B 43.21B 2,912B 43.83B 304B 119B 1,524B 115B 113B 4,864B | 32.84B 29.25B 27.11B 24.56B 46.18B 3,112B 46.83B 324B 128B 1,628B 123B 121B 5,197B |
| Net income | -4.26B -3.79B -3.51B -3.18B -5.99B -403B -6.07B -42.06B -16.53B -211B -15.97B -15.63B -674B | 10.27B 9.15B 8.48B 7.68B 14.44B 973B 14.64B 101B 39.87B 509B 38.51B 37.71B 1,625B |
| Net Debt | 21.27B 18.95B 17.56B 15.91B 29.91B 2,016B 30.34B 210B 82.6B 1,055B 79.79B 78.13B 3,367B | 13.62B 12.13B 11.24B 10.18B 19.15B 1,291B 19.42B 135B 52.88B 675B 51.08B 50.02B 2,155B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | $31.43 | +2.01% | 1,822 |
| 26-10-19 | $30.81 | -1.75% | 8,834 |
| 26-10-16 | $31.36 | -1.10% | 3,069 |
| 26-10-15 | $31.71 | +2.75% | 19,633 |
| 26-10-14 | $30.86 | +3.52% | 6,071 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
